written on 12.05.2014

Parsing Pfizer's deal talk isn't an exercise. It's the tell on AstraZeneca's future

TAGS: ,

With U.K. lawmakers skeptical of Pfizer's commitment to keep AstraZeneca jobs and AstraZeneca science in the U.K., Pfizer over the weekend released a series of videos focusing on that science–and downplaying the tax benefits CEO Ian Read crowed about so loudly when first confirming his company's trans-Atlantic bid.